BioCryst Pharmaceuticals Inc (BCRX) KPIs and segments
Close on Nov 17, 2026Market cap $1.92BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive BioCryst Pharmaceuticals's business
BioCryst Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ORLADEYO($M) | 158 | 148 | 152 | 159 | 157 | 134 | 124 | 116 | 108 | 88.9 | 90.9 | 85.7 | |
Product sales, net($M) | 158 | 151 | 159 | 158 | 162 | 144 | 129 | 116 | 108 | 89.3 | 90.7 | 85.3 | |
License and other revenues($M) | 60.7 | 5.01 | 0.92 | 1.75 | |||||||||
Other revenues($M) | 5.05 | 10.9 | 0.32 | 6.52 | 11.3 | 7.35 | 0.77 | 1.04 | 3.89 | 2.52 | 1.06 | ||
Collaborative and other revenues($M) | 2.00 | 3.38 | 1.66 | 0.92 | 1.75 | 2.19 | 1.02 | 1.35 | 3.49 | 2.66 | 1.45 | ||
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?